| ID | Name | CAS | Data |
MW (g/mol) |
| 63-970-5 |
(20S)-5«alpha»-cholestan-3«beta»,20,25-triol, TMS
|
|
2 | 637.21 |
| 64-046-0 |
Formamide, n-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-n-[4-hydroxy-1-methyl-2-(propyldithio)-1-butenyl]-
|
59-58-5 |
2 | 356.51 |
| 64-082-0 |
6«beta»-Hydroxy-17«alpha»-Methyltestosterone, tris-TMS (2,4-diene)
|
|
2 | 534.99 |
| 64-205-3 |
5«beta»-Pregnane-3«beta», 16«alpha», 20«beta»-triol, MO TMS
|
|
2 | 553.05 |
| 64-215-2 |
3A,21-Dihydroxy-5B-pregnan-11,20-dione, MO TMS
|
|
2 | 550.93 |
| 64-388-1 |
Dodecanoic acid, 9,10-epoxy-12-hydroxy, TMS-ether, OH-TMS
|
|
2 | 374.66 |
| 64-483-5 |
5-«alpha»-Pregnan-3-«alpha»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 507.90 |
| 64-524-9 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3,4-dimethoxy, butylboronate
|
|
2 | 352.23 |
| 64-525-8 |
4-Aminobenzoic acid, N,N-bis(trifluoroacetyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 443.41 |
| 64-557-3 |
P-toluenesulfonamide, alpha-(1,6-dihydro-6-oxo-9h-purin-9-yl)-
|
|
2 | 305.32 |
| 64-578-0 |
trans-Anthracene, 1,2-dihydro-1,2-diol, bis-TMS
|
|
2 | 356.61 |
| 64-640-0 |
17-«beta»-Methyl-5-«beta»-androst-1-ene-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 448.83 |
| 64-653-6 |
17«alpha»-hydroxy-5«alpha»-androstan-3-one (3-enol), per-TMS
|
|
2 | 434.80 |
| 64-669-9 |
5«beta»-Cholestane-3«alpha»,7«alpha»,24R,25-tetrol, TMS
|
|
2 | 711.37 |
| 64-874-1 |
5.alpha.-cholestan-3.beta.,17.alpha.,25-triol, DMESI
|
|
2 | 679.31 |
| 64-878-7 |
10-[3-(1-Methyl-4-piperazinyl)-2-methylpropyl]-2-trifluoromethylphenothiazine, dihydrochloride
|
|
2 | 494.44 |
| 65-032-4 |
5«beta»-Cholestane-3«alpha»,7«alpha»,25-triol, TMS
|
|
2 | 623.18 |
| 65-109-9 |
3«alpha»,6«alpha»,7«alpha»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, trimethylsilyl ether-methyl ester
|
|
2 | 727.32 |
| 65-234-0 |
5-«beta»-Pregnan-3-«alpha»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 507.90 |
| 65-271-9 |
Benzeneacetic acid, 4-[(tert-butyldimethylsilyl)oxy]-3-methoxy-, tert-butyldimethylsilyl ester
|
|
2 | 410.70 |
| 65-397-0 |
Altronic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55528-73-9 |
2 | 466.86 |
| 65-471-7 |
N-(2-Hydroxy-propionyl)-4-methyl-benzenesulfonamide, N,O-di(tert.-butyldimethylsilyl)-
|
|
2 | 471.81 |
| 65-479-9 |
Formamide, n-[4-amino-6-(benzylthio)-5-pyrimidinyl]-n-benzyl-
|
7461-79-2 |
2 | 350.44 |
| 65-584-2 |
Silane, diphenylisobutoxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 486.47 |
| 65-737-2 |
4-Hydroxy-3,4,5,5-tetra-methylthiazolidine-2-thione
|
|
2 | 191.32 |
| 65-759-8 |
3«beta»-Hydroxy-5«alpha»-androstane-7,17-dione, TMS
|
|
2 | 448.79 |
| 65-762-4 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, trimethylsilyl ester
|
|
2 | 293.82 |
| 65-766-0 |
Silane, chlorodiethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)-
|
|
2 | 272.89 |
| 65-769-7 |
Purin-6(1h)-one, 2-chloro-8-chloromethyl-7-methyl-
|
46292-82-4 |
2 | 233.06 |
| 65-894-8 |
5-Pregnen-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 551.04 |
| 65-907-3 |
L-Homoserine, N,O-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 461.90 |
| 65-966-8 |
5«beta»-Pregnane-3«alpha», 17«alpha»-diol-20-one, MO TMS
|
|
2 | 507.90 |
| 65-989-3 |
16,17-Dihydro-17-OH-GA53 methyl ester TMS ether
|
|
2 | 538.86 |
| 66-060-2 |
trans-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, butylboronate
|
|
2 | 280.17 |
| 66-063-9 |
L-Cystathionine, N,N'-bis(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
|
2 | 679.31 |
| 66-136-8 |
3«beta»,7«alpha»-Dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
2 | 522.98 |
| 66-147-6 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy, 5«alpha»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 681.22 |
| 66-165-6 |
Malonic dilactone, alpha-[2-(morpholino)ethyl]-cis-1(me),3(h),4(h)-cis-3(h)-1,8-dihydroxy-3-p-menthyl
|
|
2 | 351.44 |
| 66-209-7 |
5«alpha»-Pregnane-3«beta», 16«alpha»-diol-20-one, MO TMS
|
|
2 | 507.90 |
| 66-351-9 |
N-[4-(6-methyl)-1,3,3a,7-tetrazaindenyl]-ethylenediamine hydrochloride
|
|
2 | 192.23 |
| 66-352-8 |
1,2,3-Benzotriazine-4-(3h)-one, 6,8-dichloro-
|
60233-65-0 |
2 | 216.02 |
| 66-378-0 |
2,4(1H,3H)-Pyrimidinedione, 5-[bis(2-chloroethyl)amino]-
|
|
2 | 252.10 |
| 66-379-9 |
Butanedioic acid, 2-[(tert-butyldimethylsilyl)oxy]-, bis(tert-butyldimethylsilyl) ester
|
99461-86-6 |
2 | 476.87 |
| 66-474-3 |
6-Azido-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-L-threo-hexono-1,4-lactone
|
|
2 | 285.41 |
| 66-479-8 |
Formamide, n-[4-amino-2,6-bis-(methylthio)-5-pyrimidinyl]-
|
7595-53-1 |
2 | 230.31 |
| 66-521-0 |
[1,2,5]Thiadiazolo[3,4-d]pyrimidine, 5-amino-7-butylamino-
|
|
2 | 224.29 |
| 66-564-3 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 4
|
|
2 | 729.27 |
| 66-565-2 |
13,14-Dihydro-6,15-diketo-PGF1A, BO-TMS, isomer # 1
|
|
2 | 729.27 |
| 66-674-1 |
Allonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-34-9 |
2 | 466.86 |
| 66-675-0 |
Gulonic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55528-75-1 |
2 | 466.86 |
| 66-676-9 |
Gluconic acid, 2,3,5,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-33-8 |
2 | 466.86 |
| 66-680-4 |
5«beta»-Androstane-3,17-dione,bis-TMS, (2-en)
|
|
2 | 432.79 |
| 66-772-2 |
6'-Galactosyl-lactulose: bD-Galp(1->6)-bDGalp(1->4)-DFru, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 66-773-1 |
6'-Galactosyl-lactulose: bD-Galp(1->6)-bDGalp(1->4)-DFru, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 66-855-0 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, «omega»-PFB-oxime, TMS-enol, # 1
|
|
2 | 507.57 |
| 66-890-1 |
d-Glucose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1E)-
|
130405-10-6 |
2 | 570.10 |
| 66-915-3 |
ent-16«beta»,17-H2(OH)2 6«alpha»,7«alpha»(OH)2 kaurenoic acid, MeTMSi
|
|
2 | 671.22 |
| 67-238-4 |
6'-Glucosyl-gentobiose: aD-Glcp(1->6)-bDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 67-291-5 |
5«beta»-Androstan-6«beta»-ol-3,17-dione,tris-TMS
|
|
2 | 520.97 |
| 67-385-1 |
5-Cholesten-3-.beta.,7-.alpha.,12-.alpha.,25,26-pentol, TMS
|
|
2 | 811.58 |
| 67-452-6 |
Kojitriose: aD-Glcp(1->2)-aDGlcp(1->2)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.65 |
| 67-464-3 |
1,7-Di(2-methylbutyl)-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
2 | 380.74 |
| 67-489-6 |
1,6-Anhydro-2,3-O-isopropylidene-«beta»-D-mannopyranose, trimethylsilyl ether
|
|
2 | 274.39 |
| 67-558-9 |
ent-7«alpha»,16«beta»,17-tri-(OH)-16,17-dihydrokaurenonic acid, Me-TMS
|
|
2 | 583.03 |
| 67-643-4 |
7«alpha»,12«alpha»-dihydroxy, 3-oxy-5«beta»-cholanoate, methyl ester-trimethylsilyl ether
|
|
2 | 637.13 |
| 67-657-9 |
ent-7«alpha»,16«beta»,17-tri-(OH)-16,17-dihydrokaurenolide, Me-TMS
|
|
2 | 566.99 |
| 67-666-9 |
9,10-epoxy-18-hydroxyoctadecanoic acid, TMSi ester TMSi ether
|
|
2 | 458.83 |
| 67-679-5 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TBDMS-16,17-TFA
|
|
2 | 624.68 |
| 67-682-1 |
3«alpha»,6«beta»,7«alpha»,12«beta»-Tetrahydroxy-5«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 67-734-3 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 597.13 |
| 67-996-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3-methoxy, methylboronate
|
|
2 | 280.13 |
| 68-130-2 |
Glycine, N-(2-methyl-1-oxo-2-butenyl)-, trimethylsilyl ester, (E)-
|
55517-35-6 |
2 | 229.35 |
| 68-208-6 |
9-Dodecyn-1-ol, dimethyl(dimethyl(pyrid-3-ylmethoxy)silyloxy)silyl ether
|
|
2 | 421.72 |
| 68-340-9 |
5-«beta»-Pregnan-20-«beta»-ol-3,11-dione, MO-TMS
|
|
2 | 462.74 |
| 68-352-6 |
2,4-Imidazolidinedione, 1,3-bis(chloromethyl)-5,5-dimethyl-
|
116401-49-1 |
2 | 225.07 |
| 68-395-9 |
Inulotriose: bD-Fruf(2->1)-bDFruf(2->1)-DFru, oxime-TMS, isomer # 2
|
|
2 | 1256.35 |
| 68-487-7 |
Methyl .alpha.-D-glucopyranose, 3,4-bis-O-pentyloxymethyl ether, TMS
|
|
2 | 538.87 |
| 68-619-0 |
5-«beta»-Pregnan-11-«beta»,20-«alpha»-diol-3-one, MO-TMS
|
|
2 | 507.90 |
| 68-633-4 |
3-«alpha»,4-«beta»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 68-726-1 |
5-Amino-2-methoxyphenol, N-tert-butyldimethylsilyl-, tert-butyldimethylsilyl ether
|
|
2 | 367.67 |
| 68-804-4 |
Imidazole-4-carboxylic acid, 5-(3-cyclohexyl-3-methyl-1-triazeno)-, 2-(diethylamino)ethyl ester
|
36142-60-6 |
2 | 350.46 |
| 68-810-7 |
5«alpha»-Androstan-3«alpha»,17«beta»-diol, allyl-DMS
|
|
2 | 488.89 |
| 68-917-9 |
Acetic acid, [3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)ureido]- ethyl ester
|
7154-16-7 |
2 | 256.22 |
| 69-036-6 |
S-Triazolo(1,5-A)pyrimidine, 5-methyl-7-ethylamino-
|
|
2 | 177.21 |
| 69-096-0 |
3,18-Dioxo-11«beta»,17«alpha»-dihydroxy-4-etienic acid, 20,18-lactone, 18,11-hemiacetal, MO-TMS
|
|
2 | 445.62 |
| 69-115-8 |
2,3,4,5,7,8,9,10,11,12-Decahydro-1H-6,12a-diaza-cyclohepta[4,5]benzo[1,2]cycloocten-13-one
|
|
2 | 246.35 |
| 69-122-0 |
17-«alpha»-Methyl-5-«beta»-androst-1-ene-3-«alpha»,17-«beta»-diol, per-TMS
|
|
2 | 448.83 |
| 69-177-0 |
Urea, 1-methyl-1-nitroso-3-[2-(9h-purine-6-ylthio)ethyl]-
|
90642-35-6 |
2 | 281.29 |
| 69-198-7 |
3«alpha»,16«alpha»,17«beta»-Trihydroxy'5«beta»-androstan-11-one, tris-TMS
|
|
2 | 538.98 |
| 69-310-1 |
3-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 461.67 |
| 69-323-7 |
Ethyl (6S,7R)-8-azido-7-tert-butyldimethylsilyloxy-6-hydroxy-oct-2-enoate
|
|
2 | 357.52 |
| 69-407-4 |
3B-Hydroxy-androstan-5-en-17-one, enol, bis-TMS
|
|
2 | 446.77 |
| 69-535-2 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTMTBSi, (17-O)-TMSi
|
|
2 | 689.29 |
| 69-598-3 |
3,7,12-Trihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
2 | 637.13 |
| 69-667-6 |
5«beta»-Androst-1-ene-3«alpha»,17«beta»-diol,bis-TMS
|
|
2 | 434.80 |
| 69-668-5 |
5«beta»-Androst-1-ene-3«beta»,17«beta»-diol,bis-TMS
|
|
2 | 434.80 |
| 69-755-8 |
5«alpha»-Androst-2-en-3,17«beta»-diol, (3,17-O-)-diTMSi
|
|
2 | 434.80 |
| 69-843-0 |
Cholanic acid, 3«alpha»,7«beta»,12«alpha»-trihydroxy, Me-DMES
|
|
2 | 681.22 |
| 69-849-4 |
Arabino-hexaric acid, 2-deoxy-3,4,5-tris-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-98-9 |
2 | 555.04 |
| 69-858-4 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 2
|
|
2 | 582.96 |
|
« Previous Results
Next Results »
|